42 reports

Abstract: - Global Neglected Tropical Diseases Diagnosis Market to Reach $7.9 Billion by 2027 - Amid the COVID-19 crisis, the global market for Neglected Tropical Diseases Diagnosis estimated at US$6 Billion in the year 2020, is projected to reach a revised size of US$7.9 Billion by 2027, growing at aCAGR of 4% over...

  • Tropical Disease
  • Diagnostics
  • World
  • China
  • United States

International Stem Cell United States World Research And Development Pharmaceutical Healthcare Drug Delivery Regenerative Medicine Tropical Disease

  • Biotechnology
  • Pharmaceutical
  • Infectious Disease
  • North America
  • Freezer Sales
  • Energy Consumption

The TT##CL consortium announced that it has been awarded EUR ## million to develop an oral treatment, D##, against one of the most neglected tropical diseases, cutaneous leishmaniasis.

  • Autoimmune Disease
  • United States
  • Prescription Drug Sales
  • Medical Technology Density

Plant-made vaccines are also helping to fight against Chagas disease and other tropical diseases.

  • Infectious Disease
  • Vaccine
  • World
  • APAC
  • Middle East
  • Health Expenditure
  • Mortality Rate

There has been a massive burden of various communicable, non-communicable and tropical diseases across the Middle East & Africa region.

  • Pharmaceutical
  • Biotechnology
  • Infectious Disease
  • Beverage
  • Middle East
  • Africa
  • Health Expenditure
  • Final Consumption Expenditures

The company's products are used for the treatment of tropical infectious diseases such as enterovirus ## and coxsackievirus A##, which spreads into lymphatic system and bloodstream and causes systemic infections involving several organs.

  • Mouth Disease
  • Drug Development
  • World
  • China

Tropical Diseases

  • Infectious Disease
  • Diagnostics
  • World
  • United States
  • Europe
  • APAC
  • North America
  • Health Expenditure
  • Drug Approval

Oblita Therapeutics announced that D## is eligible to receive a FDA Priority Review Voucher upon its approval for the treatment on Leishmaniasis or another Neglected Tropical Disease.

  • Autoimmune Disease
  • Infectious Disease
  • Drug Development
  • United States
  • Medical Technology Density
  • Rural Population

Jan ##: BIOASTER awarded Grant for the development of rapid diagnostics for neglected tropical diseases

  • Infectious Disease
  • Diagnostics
  • Clinical Trial
  • United Kingdom
  • Senegal
  • United States
  • West Africa
  • Hospital Admission
  • Medical Devices Sales

The company‟s products are used for the treatment of tropical infectious diseases such as enterovirus ## and coxsackievirus A##, which spreads into lymphatic system and bloodstream and causes systemic infections involving several organs.

  • Mouth Disease
  • World
  • China
  • Pharmaceutical Exports
  • Drug Approval

Biosy nex's products are used in the therapeutic areas such as infectious diseases, emergency markers, obstetric, parasitology and virology, tropical diseases, and autoimmune diseases, among others.

  • Infectious Disease
  • Clinical Trial
  • World
  • India
  • Zhejiang
  • Pneumonia Prevalence
  • Direct Sales

In June 2013, Aix-Marseille Universite filed a patent EP##.## titled "A new chemical family to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Encephalitis
  • Drug Development
  • Japan
  • Health Provider Density
  • Infectious Disease Mortality

In June 2013, Aix-Marseille Universite filed a patent EP##.## titled "A new chemical family to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Infectious Disease
  • Drug Development
  • World
  • India
  • China
  • Health Provider Density
  • Hospital Discharge

The TT##CL consortium announced that it has been aw arded EUR ## million to develop an oral treatment, D##, against one of the most neglected tropical diseases, cutaneous leishmaniasis.

  • Autoimmune Disease
  • United States
  • Medical Technology Density
  • Rural Population

Island Pharmaceuticals is a biotechnology company that has a rapid and efficient development strategy to develop tropical disease therapies.

  • Infectious Disease
  • Drug Development
  • World
  • Asia
  • India
  • South Africa
  • Drug Approval
  • Pharmaceutical Registrations

In June 2013, Aix-Marseille Universite f iled a patent EP##.## titled "A new chemical f amily to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Infectious Disease
  • World
  • Northern Europe
  • Japan
  • Cause-Specific Mortality Rate
  • Hospital Discharge

In June 2013, Aix-Marseille Universite f iled a patent EP##.## titled "A new chemical f amily to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Encephalitis
  • Japan
  • Biologics Penetration Rate
  • Infectious Disease Mortality

In October 2014, Novartis has signed an exclusive worldwide licensing agreement with the Global Alliance for TB Drug Development (TB Alliance) for compounds to fight tuberculosis (TB) that have been discovered at the Novartis Institutes for Tropical Diseases (NITD).

  • Tuberculosis
  • Drug Development
  • World
  • South Africa
  • India
  • Sichuan
  • Chongqing Municipality
  • Guangdong
  • Tibet
  • Drug Approval
  • Stem Cell Transplantation

In June 2013, Aix-Marseille Universite filed a patent EP##.## titled "A new chemical family to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Infectious Disease
  • World
  • Northern Europe
  • Japan
  • Health Provider Density

In June 2013, Aix-Marseille Universite filed a patent EP##.## titled "A new chemical family to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Encephalitis
  • Japan
  • Biologics Penetration Rate
  • Health Provider Density

In June 2013, Aix-Marseille Universite filed a patent EP##.## titled "A new chemical family to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Infectious Disease
  • Drug Development
  • World
  • United States
  • Asia
  • Japan
  • India
  • South Africa
  • Drug Approval
  • Pharmaceutical Registrations

In September 2010, Themis Bioscience formed a joint R&D program collaboration with Institut Pasteur to fight tropical infectious diseases including chickungunya.

  • Infectious Disease
  • Drug Development
  • World
  • Toyama Prefecture
  • Drug Approval
  • Pharmaceutical Registrations

In June 2013, Aix-Marseille Universite filed a patent EP##.## titled "A new chemical family to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Infectious Disease
  • United States
  • Japan
  • Drug Approval
  • Pharmaceutical Registrations

In September 2010, Themis Bioscience formed a joint R&D program collaboration with Institut Pasteur to fight tropical infectious diseases including chickungunya.

  • Infectious Disease
  • World
  • India
  • Hawaii
  • Drug Approval
  • Surgical Procedures Performed

In 2020, Novartis Institute for Tropical Diseases (NITD) discovered malaria therapy.

  • Malaria
  • Drug Development
  • World
  • India
  • South Africa
  • Pharmaceutical Registrations
  • Drug Approval

The company stated that ATI-## is eligible for a Neglected Tropical Disease Priority Review Voucher if first approved by the U.S. Food and Drug Administration (FDA) for the treatment of cryptococcal meningitis

  • Meningococcal
  • Drug Development
  • World
  • India
  • Chongqing Municipality
  • Jiangsu
  • Liaoning
  • HIV AIDS Prevalence
  • HIV AIDS Mortality Rate

The company stated that ATI-## is eligible for a Neglected Tropical Disease Priority Review Voucher if first approved by the U.S. Food and Drug Administration (FDA) for the treatment of cryptococcal meningitis

  • Infectious Disease
  • Drug Development
  • World
  • South Africa
  • Toyama Prefecture
  • Shaanxi
  • Drug Approval
  • Pharmaceutical Registrations

For instance, the Italian Society of Infectious and Tropical Diseases (SIMIT) represented physicians, scientists and other healthcare professionals that specialize in the infectious diseases with an aim to improve the diagnosis, treatment and prevention of these diseases.

  • Infectious Disease
  • APAC
  • World
  • United States
  • Europe
  • North America
  • Drug Approval
  • Health Expenditure

In June 2013, Aix-Marseille Universite filed a patent EP##.## titled "A new chemical family to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Infectious Disease
  • Japan
  • Drug Approval
  • Pharmaceutical Registrations

The company stated that ATI-## is eligible for a Neglected Tropical Disease Priority Review Voucher if first approved by the U.S. Food and Drug Administration (FDA) for the treatment of cryptococcal meningitis

  • Meningococcal
  • World
  • Toyama Prefecture
  • Chongqing Municipality
  • HIV AIDS Prevalence
  • Diagnostic Imaging Density